| A Study of PEG-rhG-CSF and rhG-CSF Used for Aplastic Anemia Granulocyte Deficiency (NCT05531279) | Institute of Hematology & Blood Diseases Hospital, China | 2022-06-05 |
| Efficacy and Safety of CSA and Avatrombopag for the Treatment of SAA in the Elderly (NCT05433922) | Institute of Hematology & Blood Diseases Hospital, China | 2022-06-01 |
| Up-front Matched Unrelated Donor Transplantation in Pediatric Patients With Idiopathic Aplastic Anemia (NCT05419843) | Assistance Publique - Hôpitaux de Paris | 2022-06-01 |
| Natural History of Acquired and Inherited Bone Marrow Failure Syndromes (NCT05012111) | National Heart, Lung, and Blood Institute (NHLBI) | 2021-10-25 |
| RACE 2: a Long Term Follow-up of Patients Participating in the RACE Trial (NCT05049668) | European Society for Blood and Marrow Transplantation | 2021-10-01 |
| AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion (NCT04099966) | Mitchell Cairo | 2021-04-01 |
| TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children (NCT04356469) | Johns Hopkins All Children's Hospital | 2020-07-22 |
| Retrospective Study of Patients With Severe Aplastic Anemia Who Relapsed After Immunosuppressive Therapy (NCT04436380) | National Heart, Lung, and Blood Institute (NHLBI) | 2020-06-15 |
| Retrospective Study of Patients With Severe Aplastic Anemia Who Developed High Risk Clonal Evolution With Chromosome 7 Abnormalities After Immunosuppressive Therapy (NCT04436367) | National Heart, Lung, and Blood Institute (NHLBI) | 2020-06-15 |
| Early Initiation of Oral Therapy With Cyclosporine and Eltrombopag for Treatment Naive Severe Aplastic Anemia (SAA) (NCT04304820) | National Heart, Lung, and Blood Institute (NHLBI) | 2020-05-07 |
| Transfer of Effector Memory T Cells (Tem) Following Allogeneic Stem Cell Transplantation (NCT03836690) | University College, London | 2019-10-21 |
| Hetrombopag or Placebo in Treatment-Naive Severe Aplastic Anemia (NCT03825744) | Jiangsu HengRui Medicine Co., Ltd. | 2019-03-05 |
| Peripheral Blood Allogenic Stem Cell Transplantation Using Non-anti Thymocyte Globulin Regimens in Severe Aplastic Anemia Patients (NCT03295058) | Assiut University | 2019-01-01 |
| Alpha/Beta TCD HCT in Patients With Inherited BMF Disorders (NCT03579875) | Masonic Cancer Center, University of Minnesota | 2018-11-13 |
| A Study to Evaluate the Safety and Efficacy of Hetrombopag Olamine in Severe Aplastic Anemia （SAA） Patient (NCT03557099) | Jiangsu HengRui Medicine Co., Ltd. | 2018-06-20 |
| Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer (NCT03333486) | Roswell Park Cancer Institute | 2017-12-07 |
| Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant (NCT03192397) | Roswell Park Cancer Institute | 2017-08-09 |
| Haploidentical Transplantation in Severe Aplastic Anemia (NCT03246178) | Wu Xiaoxiong | 2017-07-10 |
| Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502) (NCT02918292) | Medical College of Wisconsin | 2017-07-03 |
| Unrelated Umbilical Cord Blood Transplantation for Severe Aplastic Anemia and Hypo-plastic MDS Using CordIn(TM), Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells to Expedite Engraftment and Improve Transplant Outcome (NCT03173937) | National Heart, Lung, and Blood Institute (NHLBI) | 2017-06-13 |
| Eltrombopag Combined With Cyclosporine as First Line Therapy in Patients With Severe Acquired Aplastic Anemia (NCT02998645) | Novartis Pharmaceuticals | 2017-05-11 |
| Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy (NCT02979873) | National Heart, Lung, and Blood Institute (NHLBI) | 2016-12-19 |
| Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic Anemia (NCT02828592) | Northside Hospital, Inc. | 2016-09-09 |
| NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia (NCT02833805) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2016-09-01 |
| Unrelated Donor Transplant Versus Immune Therapy in Pediatric Severe Aplastic Anemia (NCT02845596) | Michael Pulsipher | 2016-08-01 |
| The Efficacy of Immunosuppressive Therapy Combined With Cord Blood Transfusion in Treatment of Severe Aplastic Anemia (NCT02745717) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2016-01-01 |
| hATG+CsA vs hATG+CsA+Eltrombopag for SAA (NCT02099747) | European Society for Blood and Marrow Transplantation | 2015-07-01 |
| Safety and Efficacy of Patient's Own AD-MSC and AD-HSC Transplantation in Patients With Severe Aplastic Anemia (NCT02407470) | Navy General Hospital, Beijing | 2015-01-01 |
| Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia (NCT02224872) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2014-08-01 |
| Bone Marrow Transplant With Abatacept for Non-Malignant Diseases (NCT01917708) | Emory University | 2014-01-01 |
| Post Transplant Cyclophosphamide (Cytoxan) for GvHD Prophylaxis (NCT02065154) | University of Alabama at Birmingham | 2013-08-27 |
| Human Placental-Derived Stem Cell Transplantation (NCT01586455) | New York Medical College | 2013-04-01 |
| CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation (NCT01966367) | Diane George | 2013-03-01 |
| Mesenchymal Stem Cells Co-transplantation in Alternative Donor Transplantation of Severe Aplastic Anemia. (NCT02247973) | Guangzhou General Hospital of Guangzhou Military Command | 2013-02-01 |
| Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia (NCT01703169) | University of Utah | 2012-11-01 |
| Eltrombopag With Standard Immunosuppression for Severe Aplastic Anemia (NCT01623167) | National Heart, Lung, and Blood Institute (NHLBI) | 2012-07-02 |
| A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) (NCT01351545) | Center for International Blood and Marrow Transplant Research | 2011-10-01 |
| Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation (NCT01472055) | Seoul National University Hospital | 2011-10-01 |
| Bone Marrow Transplant Trial for Patients With Refractory Severe Aplastic Anemia (NCT01383434) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2011-06-01 |
| Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells (NCT01174108) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-12-10 |
| Different Doses of Anti-thymocyte Globin to Treat Child Severe Aplastic Anemia (NCT01997372) | Chinese Academy of Medical Sciences | 2010-12-01 |
| Alefacept and Allogeneic Hematopoietic Stem Cell Transplantation (NCT01319851) | Emory University | 2010-09-01 |
| A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia (NCT01187017) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-08-01 |
| Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia (NCT01193283) | National Heart, Lung, and Blood Institute (NHLBI) | 2010-08-01 |
| Unrelated Umbilical Cord Blood (UBC)Transplantation (NCT01768845) | West Virginia University | 2009-02-03 |
| Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders (NCT00358657) | Fred Hutchinson Cancer Center | 2006-05-24 |
| Unrelated Donor Stem Cell Transplantation (NCT01364363) | Scripps Health | 2005-03-01 |
| Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia (NCT00061360) | National Heart, Lung, and Blood Institute (NHLBI) | 2003-06-26 |
| Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT (NCT00516152) | University of California, San Francisco | 2002-11-01 |
| Antibody Conditioning Regimen For Allogeneic Donor Stem Cell Transplantation Of Patients With Fanconi Anemia (NCT00590460) | Baylor College of Medicine | 2001-07-01 |
| Combination Therapy of Severe Aplastic Anemia (NCT00001964) | National Heart, Lung, and Blood Institute (NHLBI) | 2000-03-17 |
| Allogeneic Mixed Chimerism Stem Cell Transplant Using Campath for Hemoglobinopathies & Bone Marrow Failure Syndromes (NCT00004143) | David Rizzieri, MD | 1999-09-01 |